Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$10.19M$10.19Mderived+81.2% vs Q4 2020 Net Income-$1.77M-$1.77MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,162,362N/M Operating Cash Flowderived$1,333,834N/M Free Cash Flowderived$1,307,948N/M Margins · derivedOperating margin-11.4%−14.4 pt vs Q4 2020
Net margin-17.3%−40.5 pt vs Q4 2020
ended Dec 31, 2021 · filed Aug 26, 2022 · 238 d after period end